Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Equity ETF median (66 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Nov 2021 – 20 Aug 2026, limited by Aditya Birla Sun Life Nifty IT ETF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Aditya Birla Sun Life Nifty IT ETF | Nifty 500 |
|---|---|---|
| 03 Nov 2021 | ₹100.00 | ₹100.00 |
| 29 Mar 2022 | ₹102.91 | ₹96.59 |
| 22 Aug 2022 | ₹84.97 | ₹98.16 |
| 15 Jan 2023 | ₹83.83 | ₹100.41 |
| 10 Jun 2023 | ₹82.61 | ₹103.89 |
| 03 Nov 2023 | ₹90.59 | ₹111.24 |
| 28 Mar 2024 | ₹102.82 | ₹132.54 |
| 20 Aug 2024 | ₹123.58 | ₹152.33 |
| 13 Jan 2025 | ₹131.37 | ₹139.00 |
| 08 Jun 2025 | ₹112.73 | ₹151.58 |
| 01 Nov 2025 | ₹109.07 | ₹155.14 |
| 27 Mar 2026 | ₹90.92 | ₹137.54 |
| 20 Aug 2026 | ₹95.68 | ₹153.85 |
| Metric | Aditya Birla Sun Life NAV ₹33.61 Very High risk ★☆☆☆☆ | Category median Equity ETF · 66 funds |
|---|---|---|
| -11.61% | +3.95% | |
| +2.23% | +11.55% | |
| — | +10.41% | |
| — | +11.81% | |
| -0.92% | +8.19% | |
| -1.17% | — | |
| +7.07% | +13.71% | |
| — | +14.22% | |
| — | +12.98% | |
| Risk | ||
| 22.05% | 17.16% | |
| -0.19 | 0.22 | |
| -0.28 | 0.32 | |
| -41.62% | -20.98% | |
| Nifty 500 | — | |
| -6.10% | +0.65% | |
| 0.76 | 1.00 | |
| 41.4% | 101.0% | |
| 62.7% | 97.0% | |
| 0.25% | 0.37% | |
| ₹60.92Cr | ₹91.02Cr | |
| None | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| Priya Sridhar | — | |
| 03 Nov 2021 | — | |
| 10 | — | |
| 99.8% | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.